Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Regeneron Pharmaceuticals

Market Cap: US$51.8b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Daiichi Sankyo Company

Market Cap: JP¥7.2t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Summit Therapeutics

Market Cap: US$13.5b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

ALTEOGEN

Market Cap: ₩17.6t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

BioMarin Pharmaceutical

Market Cap: US$11.1b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Moderna

Market Cap: US$10.3b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Corcept Therapeutics

Market Cap: US$8.2b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Roivant Sciences

Market Cap: US$7.5b

A clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of medicines and technologies.

Revolution Medicines

Market Cap: US$7.3b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Grifols

Market Cap: €5.9b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Jazz Pharmaceuticals

Market Cap: US$6.7b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Repligen

Market Cap: US$6.6b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

BridgeBio Pharma

Market Cap: US$6.5b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Chongqing Zhifei Biological Products

Market Cap: CN¥45.8b

Chongqing Zhifei Biological Products Co., Ltd.

Madrigal Pharmaceuticals

Market Cap: US$6.1b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Bruker

Market Cap: US$5.6b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Legend Biotech

Market Cap: US$5.3b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Ionis Pharmaceuticals

Market Cap: US$5.3b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Axsome Therapeutics

Market Cap: US$5.2b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Zealand Pharma

Market Cap: DKK 32.1b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

Vaxcyte

Market Cap: US$4.2b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Akero Therapeutics

Market Cap: US$4.0b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

Merus

Market Cap: US$3.9b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Avidity Biosciences

Market Cap: US$3.7b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Cytokinetics

Market Cap: US$3.7b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Soleno Therapeutics

Market Cap: US$3.7b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Sarepta Therapeutics

Market Cap: US$3.7b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Krystal Biotech

Market Cap: US$3.6b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Genscript Biotech

Market Cap: HK$27.9b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Alvotech

Market Cap: US$3.5b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Arcellx

Market Cap: US$3.4b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Zai Lab

Market Cap: US$3.3b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Ultragenyx Pharmaceutical

Market Cap: US$3.2b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

CRISPR Therapeutics

Market Cap: US$3.1b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Viking Therapeutics

Market Cap: US$3.0b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Crinetics Pharmaceuticals

Market Cap: US$2.9b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.